METiS Therapeutics

Curated by Signal

Provider of an AI-assisted platform for drug discovery and development

Overview

Provider of an AI-assisted platform for drug discovery and development. The company utilizes machine learning algorithms to identify clinical candidate molecules with the advanced prediction of pharmaceutical properties. It aids researchers with the optimization and selection of small molecules for different therapeutic purposes.

Key facts

Founded: 2017
Headquarters: Cambridge, United States
Stage: Sign up to view
Industry: Health Technology

Business model

4 products and services: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

HealthSnap
Digital platform for remote patient monitoring
Health TechnologyMiami, United States
LUCIRA
Provider of home-based diagnostic solutions for infectious diseases
Health TechnologyEmeryville, United States
Fitely
Fit store for the purchase of accessories and supplements
Health TechnologyJordan, United States

About METiS Therapeutics

What does METiS Therapeutics do?

Provider of an AI-assisted platform for drug discovery and development.

Where is METiS Therapeutics headquartered?

METiS Therapeutics is headquartered in Cambridge, United States.

When was METiS Therapeutics founded?

METiS Therapeutics was founded in 2017.

Which sector is METiS Therapeutics in?

METiS Therapeutics operates in Health Technology.

Who are METiS Therapeutics's competitors?

Companies similar to METiS Therapeutics include HealthSnap, LUCIRA, and Fitely.